CG
IBIO icon

Cutler Group’s iBio IBIO Stock Holding History

Cutler Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed – – 4019
2023
Q2 		$0 Hold
10
– – ﹤0.01% 3844
2023
Q1 		$0 Buy
+10
New +$257 ﹤0.01% 4220
2022
Q4 		– Sell
-7
Closed -$237 – 4739
2022
Q3 		$0 Sell
7
-3
-30% -$413 ﹤0.01% 5170
2022
Q2 		$1K Hold
10
– – ﹤0.01% 4609
2022
Q1 		$2K Buy
10
+4
+67% +$837 ﹤0.01% 4679
2021
Q4 		$1K Sell
6
-12
-67% -$4.58K ﹤0.01% 5023
2021
Q3 		$9K Buy
18
+12
+200% +$7.47K ﹤0.01% 4012
2021
Q2 		$4K Hold
6
– – ﹤0.01% 4591
2021
Q1 		$4K Sell
6
-2
-25% -$1.74K ﹤0.01% 4513
2020
Q4 		$4K Buy
8
+3
+60% +$2.44K ﹤0.01% 3786
2020
Q3 		$5K Buy
+5
New +$7.25K ﹤0.01% 3498

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cutler Group's IBIO Position: Q3 2023 in Review

Cutler Group sold out of iBio (IBIO) in Q3 2023, closing a stake of 10 shares.

Cutler Group first reported a position in IBIO in Q3 2020 and held it in 11 quarters. The position peaked at $9K in Q3 2021. 26 funds tracked by Wall St. Rank hold IBIO as of Q3 2023.

  • Cutler Group reported no remaining iBio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 10 iBio shares in Q3 2023.
  • Cutler Group first reported a position in iBio in Q3 2020 and held it in 11 quarters.
  • Cutler Group's iBio position peaked at $9K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held iBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.